Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Vitrolife

154.5

 

SEK

 

-0.45 %

Less than 1K followers

VITR

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Ownership
Investor consensus
Compare
-0.45%
-1.97%
-21.57%
-28.14%
-31.27%
-16.35%
-42.99%
-19.49%
+2,417.52%

Vitrolife is a global provider of solutions in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics in enhancing their practice as well as the outcome of a patient’s fertility treatment. Vitrolife´s products and services are available globally, and the company is headquartered in Gothenburg, Sweden.

Read more
Market cap
20.93B SEK
Turnover
1.75M SEK
Revenue
3.61B
EBIT %
21.7 %
P/E
40.77
Dividend yield-%
0.71 %
Financial calendar
17/7
2025

Interim report Q2'25

23/10
2025

Interim report Q3'25

29/1
2026

Annual report '25

All
Press releases
3rd party
ShowingAll content types
Press release5/8/2025, 1:49 PM

Vitrolife AB (publ) becomes lead investor in AutoIVF

Vitrolife
Press release5/8/2025, 1:49 PM

Vitrolife AB (publ) går in som huvudinvesterare i AutoIVF

Vitrolife
Regulatory press release4/30/2025, 7:08 AM

Kommuniké från årsstämma i Vitrolife AB (publ)

Vitrolife

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release4/30/2025, 7:08 AM

Report from Annual General Meeting of Vitrolife AB (publ)

Vitrolife
Regulatory press release4/29/2025, 2:56 PM

Report from Annual General Meeting of Vitrolife AB (publ)

Vitrolife
Regulatory press release4/29/2025, 2:56 PM

Kommuniké från årsstämma i Vitrolife AB (publ)

Vitrolife
Press release4/28/2025, 8:03 AM

Redeye: Vitrolife Update - Good efforts in a challenging period

Vitrolife
Regulatory press release4/24/2025, 6:00 AM

Vitrolife AB (publ): Interim report Q1, 2025: Strong performance in EMEA

Vitrolife
Regulatory press release4/24/2025, 6:00 AM

Vitrolife AB (publ): Delårsrapport Q1, 2025: Starkt resultat i EMEA

Vitrolife
Regulatory press release4/10/2025, 10:00 AM

Vitrolife AB (publ): The Vitrolife Group appoints Pär Ihrskog as the new Chief Financial Officer

Vitrolife
Regulatory press release4/10/2025, 10:00 AM

Vitrolife AB (publ): Vitrolife Group utser Pär Ihrskog till ny Chief Financial Officer

Vitrolife
Press release4/10/2025, 8:00 AM

Vitrolife AB (publ): Telefonkonferens avseende delårsrapport

Vitrolife
Press release4/10/2025, 8:00 AM

Vitrolife AB (publ): Conference call interim report

Vitrolife
Regulatory press release3/31/2025, 9:30 AM

Vitrolife AB (publ): The Vitrolife Group introduces changes to the executive management team and strengthens focus on innovation

Vitrolife
Regulatory press release3/31/2025, 9:30 AM

Vitrolife AB (publ): Vitrolife Group inför förändringar i koncernledningen samt stärker fokus på innovation

Vitrolife
Regulatory press release3/27/2025, 8:00 AM

Vitrolife AB (publ): Vitrolife Group Annual and Sustainability Report 2024

Vitrolife
Regulatory press release3/27/2025, 8:00 AM

Vitrolife AB (publ): Vitrolife Group Års- och hållbarhetsredovisning 2024

Vitrolife
Regulatory press release3/25/2025, 5:30 PM

Kallelse till årsstämma i Vitrolife AB (publ)

Vitrolife
Regulatory press release3/25/2025, 5:30 PM

Notice to attend the Annual General Meeting of Vitrolife AB (publ)

Vitrolife
Press release3/24/2025, 9:25 AM

Redeye: Vitrolife - Enters 2025 fighting

Vitrolife
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team